Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Sickweather storms market with overfunded $1M crowdfunding campaign amid flu season
An illness forecaster is never more valuable than when the threat of a widespread virus is high. This year’s severe flu season, however, is only one of the leading contributors to Sickweather’s uptick in interest — and its recent oversubscribed $1 million crowdfunding campaign, said founder Graham Dodge. “We learn a lot every cold and…
Fund Me, KC: Operation Breakthrough hopes to burn into STEM gap with laser cutter
Editor’s note: Startland News is continuing its ‘Fund Me, KC’ feature to highlight area entrepreneurial efforts to accelerate businesses or projects. If you or your startup is running a crowdfunding campaign, let us know by contacting news@startlandnews.com. Today’s featured campaign from Operation Breakthrough spotlights a campaign by the nonprofit childhood development center to boost its…
designWerx makes room for growing makers in North Kansas City
A home garage workspace can be a lonely, stifling place for a maker trying to grow his or her business, said Pam Newton, who is leading the artistic vision for designWerx, a new coworking space and incubator specifically for makers in North Kansas City. “You’re alone constantly. Sometimes it’s hard to get motivated,” she said.…
KCultivator Q&A: Tyler Enders talks his biggest failure, the ‘Made In’ concept and Obama
Seated amid vintage mosaic tile and striking black-and-white portraits by Kansas City photographer Cameron Gee, founder Tyler Enders seems at home within the walls of the Made in KC Cafe. He’s an art lover with a finance degree — not to mention one of the minds behind Made in KC, a retail showcase for local…